Multi-Omics Analysis Identifies MGA as a Negative Regulator of the MYC Pathway in Lung Adenocarcinoma
Paula Llabata(Institut d'Investigació Biomédica de Bellvitge), Xiaoyang Zhang(University of Utah), Namrata D. Udeshi(Harvard University), Tanya Svinkina(Broad Institute), Yoichiro Mitsuishi(Tohoku University), Zhong Wu(Nanfang Hospital), Steven A. Carr(Broad Institute), Matthew Meyerson(Broad Institute), Estrella Aguilera-Jimenez(Huntsman Cancer Institute), Diana Cai(Broad Institute), Jin Zhou(The University of Texas Southwestern Medical Center), Manuel Torres-Diz(Children's Hospital of Philadelphia), Lior Golomb(Broad Institute), Joshua M. Francis(Broad Institute), Montse Sánchez‐Céspedes(Josep Carreras Leukaemia Research Institute), Yanli Liu(National Medical Products Administration), Peter S. Choi(Children's Hospital of Philadelphia)
Cited by 53
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
|Science|2006|5.5k
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Oncogenic Signaling Pathways in The Cancer Genome Atlas
|Cell|2018|3.4k